<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The immediate clinical course of 42 patients with <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> secondary to <z:e sem="disease" ids="C0035439" disease_type="Disease or Syndrome" abbrv="rhd">rheumatic heart disease</z:e> (RHD) was analyzed retrospectively </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the cases included cranial computed tomographic (CT) findings </plain></SENT>
<SENT sid="2" pm="."><plain>Twenty-five patients received early <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy (AT) and 17 did not </plain></SENT>
<SENT sid="3" pm="."><plain>Recurrent embolic events occurred in only one case </plain></SENT>
<SENT sid="4" pm="."><plain>Seven instances of hemorrhagic infarction (HI) were found </plain></SENT>
<SENT sid="5" pm="."><plain>In five cases, the development of HI correlated with a recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo>, which occurred in each case within 48 hours after the initial <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Three of the patients with HI died (<z:hpo ids='HP_0000001'>all</z:hpo> of them were receiving AT) </plain></SENT>
<SENT sid="7" pm="."><plain>We believe that HI is a frequent cause of recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> after a cerebral embolic event, that it generally occurs in the first 48 hours, and that its outcome is possibly worsened by AT </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="3" ids="50249">Anticoagulant</z:chebi> therapy should be delayed for three days after a cerebral embolic event secondary to RHD </plain></SENT>
</text></document>